Outcome of Idiopathic Macular Hole

NCT00941291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2009-07-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).

Conditions

  • Idiopathic Macular Hole

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Principal Investigators

  • Catherine Creuzot-Gracher, MD, PhD · Ophthalmology unit CHU Dijon

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2005-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00941291 on ClinicalTrials.gov